Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06798363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 21, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later Jun 30, 2026 → Sep 30, 2026
Enrollment reduced 40% 40 → 24 participants
See other at-risk trials from West China Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 30, 2026 to Sep 30, 2026 Show 6 more changesShow less
    • Enrollment increased: 24 → 32 participants
    • Study completion pushed from Aug 1, 2026 to Mar 30, 2027
    • Study sites: 1 to 3
    • Start date: May 2, 2025 to Jan 1, 2025
    • Secondary endpoints: details revised at 2 of 2 entries
    • Eligibility criteria expanded, about 2 words
  2. Enrollment reduced: 40 → 24 participantsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2, 2025 to May 2, 2025
    • Site details revised
    v3
  4. Phase: Phase 1/2 to Phase 2/3
    • Start date: Feb 1, 2025 to Apr 2, 2025
    • Eligibility criteria shortened, about 2 words
    • Study title expanded, about 4 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).
Trial Details
NCT Number NCT06798363
Lead Sponsor West China Hospital
Conditions
(from sponsor)		 Infantile Hemangioma
Related terms Hemangioma, Capillary, Ulcer
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov